AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
CMS’s WISeR Review Program Could Reshape How Healthcare Ops Are Audited
CMS’s WISeR AI review initiative is drawing attention for its potential to alter how utilization and operational decisions are scrutinized. Health systems and vendors may face new friction as AI-assisted review becomes a more consequential part of the reimbursement environment.
How Bunkerhill Health’s CMS Win Signals a New Business Model for AI Cardiology
Bunkerhill Health has secured CMS payment for its AI-based cardiac analysis, a milestone that matters as much for reimbursement as for technology. The decision suggests AI tools are moving from pilot projects into the messy but crucial economics of routine care.
CMS Moves AI From Policy Concept to Deployment Reality
A Hogan Lovells analysis says CMS’s health tech ecosystem is shifting from vision to deployment, a sign that federal health IT policy is beginning to shape real-world AI adoption. The transition matters because coverage, reimbursement, and interoperability will decide which tools actually reach clinicians.
FDA and CMS Sketch a New Coverage Pathway That Could Shorten the Access Gap for Medical Devices
FDA and CMS have outlined a new pathway intended to speed Medicare coverage decisions for medical devices. If implemented well, it could reduce the long lag between regulatory clearance and real-world patient access. The move signals a broader federal effort to align evidence, reimbursement, and adoption more closely for innovative devices.
FDA and CMS Outline a New Medicare Access Pathway as Device Policy Converges
FDA and CMS have outlined a new Medicare coverage pathway for medical device access, reinforcing the growing convergence between approval and payment policy. The move could make it easier for innovators to turn regulatory success into real patient adoption.
CMS Pushes Prior Authorization Automation, Signaling a Bigger Administrative AI Shift
CMS has added an electronic prior authorization pledge to its health tech ecosystem, a move that could accelerate one of healthcare's most painful administrative workflows. If implementation follows the policy rhetoric, this could become a meaningful test of whether AI and automation can reduce friction without creating new bureaucracy.
FDA Accelerates Medicare Coverage for Breakthrough Medical Devices
The FDA and CMS are moving to speed Medicare coverage for breakthrough devices, reinforcing a broader push to shorten the path from innovation to reimbursement. The move is especially significant for companies that have often seen promising products stall after approval because payment decisions came too late.
CMS and FDA align on a breakthrough device coverage pathway, putting reimbursement on a faster track
CMS and FDA have announced a new pathway intended to accelerate Medicare coverage for breakthrough medical devices. The policy could help promising technologies get to market faster by reducing the uncertainty that often follows regulatory approval. It also underscores how central reimbursement has become to the success of medical innovation.
CMS rolls out RAPID coverage program to accelerate access to breakthrough medical devices
CMS and FDA are launching RAPID, a program aimed at speeding Medicare coverage for breakthrough devices. The idea is to reduce the delay between approval and real-world use, a gap that has long frustrated innovators and patients alike. If successful, RAPID could become a template for broader reimbursement reform in medtech.
FDA and CMS outline a new Medicare coverage pathway that could reshape medical device access
A new CMS-FDA pathway is designed to streamline Medicare coverage for breakthrough medical devices. The change could make access faster and more predictable for patients, providers, and investors. The big question is whether speed can be improved without weakening evidence standards.
CMS and FDA launch RAPID pathway to speed Medicare coverage for breakthrough devices
CMS and the FDA have unveiled a new coverage pathway designed to shorten the lag between a breakthrough device’s regulatory approval and Medicare reimbursement. The move could materially improve early patient access, especially for devices aimed at urgent or life-altering conditions. But the policy also raises questions about how much evidence will be enough when coverage decisions are being made faster than ever.
FDA and CMS unveil faster Medicare coverage route for breakthrough medical devices
Federal health officials have introduced a new pathway to speed Medicare coverage for breakthrough devices. The initiative is part reimbursement reform, part innovation policy, and it could reshape how quickly new medtech products reach routine use. The broader significance is that U.S. device access is becoming more explicitly tied to coordinated regulatory and payment decisions.
CMS and FDA Unveil a Faster Medicare Path for Breakthrough Devices
Federal regulators are creating a new pathway to accelerate Medicare coverage decisions for breakthrough medical devices, aiming to shorten the gap between FDA authorization and patient access. The move could be a major win for device makers, but it also raises questions about evidentiary standards, payer discretion, and whether speed will outpace real-world validation.
U.S. Regulators Move to Speed Medicare Coverage for Breakthrough Devices
The FDA and CMS are rolling out a new effort to accelerate Medicare coverage for breakthrough devices, signaling a more coordinated federal approach to innovation. The policy could reduce commercialization delays, but it may also intensify scrutiny over what level of evidence should be enough for public payment.
CMS, FDA Launch New Coverage Program for Breakthrough Medical Devices
CMS and the FDA have announced a new program intended to make Medicare coverage decisions for breakthrough devices faster and more coordinated. The initiative could reshape how innovative hardware reaches older adults, but it will test how much uncertainty public payers are willing to absorb.
January AI Lands in the Medicare App Library, Bringing Personalized Health Insights to a Federal Audience
January AI is among the first third-party apps available in the CMS Medicare App Library, a notable milestone for consumer health AI. The move could expand access to personalized insights, while also signaling that federal distribution channels are starting to shape digital health adoption.
CMS Eyes Backward Step on Breakthrough Device Payment Flexibilities
CMS is proposing to roll back some payment flexibilities for breakthrough devices, potentially making it harder for innovative technologies to gain early market traction. The move could reshape how device makers think about reimbursement as much as regulation.
CMS Enlists 150 Digital Health Players for Its ACCESS Model, Signaling a Bigger Role for the Sector in Medicare Innovation
CMS is pulling a wide range of digital health companies and providers into its ACCESS Model, a sign that federal payment and care redesign efforts are increasingly leaning on commercial health tech. The move could give the agency a broader test bed for remote monitoring, virtual care, and AI-enabled workflows while also raising questions about interoperability, oversight, and reimbursement. If successful, the model may shape how digital health participates in Medicare at scale.
EFF Lawsuit Against CMS Puts AI Prior Authorization Under a Sharper Legal Microscope
The Electronic Frontier Foundation has sued CMS over an AI prior authorization demonstration, escalating legal scrutiny of algorithmic decision-making in public insurance programs. The case could become a major test of transparency, accountability and due process in healthcare automation.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.